Patients receiving Enbrel for inflammatory diseases other than inflammatory bowel disease have an increased risk for a diagnosis of Crohn’s disease or ulcerative colitis, according to study results.
Joshua Korzenik, MD, director of the Crohn’s and Colitis Center at Brigham and Women’s Hospital, and colleagues wrote in Alimentary Pharmacology & Therapeutics that anti-TNF treatments have made a significant impact on the management of autoimmune disease like rheumatoid arthritis and IBD. However, they do not come without risks.
“Paradoxically, these agents might provoke

Source link